ATI RN
Physical Exam Cardiovascular System
1. What is the condition where the walls of the heart's ventricles become thickened, reducing the heart's ability to pump blood effectively?
- A. Ventricular hypertrophy
- B. Atrial fibrillation
- C. Restrictive cardiomyopathy
- D. Cardiomyopathy
Correct answer: A
Rationale: Ventricular hypertrophy is the correct answer. In ventricular hypertrophy, the walls of the heart's ventricles become thickened, which decreases the heart's efficiency in pumping blood. Atrial fibrillation (choice B) is an irregular and often rapid heart rate that can lead to poor blood flow. While restrictive cardiomyopathy (choice C) involves the heart muscle becoming rigid and less compliant, it is not specifically characterized by thickening of the ventricular walls. Cardiomyopathy (choice D) is a general term for diseases of the heart muscle, which can present with various symptoms and causes.
2. What is a condition where the heart beats with an irregular or abnormal rhythm?
- A. Arrhythmia
- B. Hypertension
- C. Tachycardia
- D. Bradycardia
Correct answer: A
Rationale: Arrhythmia is the correct answer because it refers to an irregular or abnormal heart rhythm, which can cause the heart to beat too fast, too slow, or erratically. Hypertension (choice B) is high blood pressure and not directly related to irregular heart rhythm. Tachycardia (choice C) is a condition where the heart beats too quickly, not necessarily irregularly. Bradycardia (choice D) is a condition where the heart beats too slowly, not necessarily irregularly. Therefore, only arrhythmia (choice A) fits the description provided in the question.
3. What is a condition where the walls of the arteries in the lungs become thickened and stiff, leading to increased blood pressure in the pulmonary arteries?
- A. Pulmonary hypertension
- B. Pulmonary fibrosis
- C. Pulmonary embolism
- D. Pulmonary edema
Correct answer: A
Rationale: Pulmonary hypertension is a condition characterized by the thickening and stiffening of the arteries in the lungs, resulting in elevated blood pressure in the pulmonary arteries. This condition is distinct from the other choices provided. Pulmonary fibrosis involves scarring of lung tissue, pulmonary embolism is a blockage in the pulmonary artery, and pulmonary edema is the accumulation of fluid in the lungs.
4. The client on digoxin has a potassium level of 3.0 mEq/L. What is the nurse’s priority action?
- A. Administer a potassium supplement
- B. Hold the digoxin and notify the healthcare provider
- C. Continue the current digoxin dose
- D. Administer Digibind
Correct answer: B
Rationale: The correct answer is to hold the digoxin and notify the healthcare provider. A potassium level of 3.0 mEq/L indicates hypokalemia, which can increase the risk of digoxin toxicity. Digoxin and low potassium levels can lead to serious cardiac arrhythmias. Administering a potassium supplement (choice A) without healthcare provider guidance can worsen the situation. Continuing the current digoxin dose (choice C) can further increase the risk of toxicity. Administering Digibind (choice D) is used in severe cases of digoxin toxicity, not for addressing low potassium levels.
5. The client is receiving digoxin and has a potassium level of 2.8 mEq/L. What is the nurse’s priority action?
- A. Hold the digoxin and notify the healthcare provider.
- B. Increase the dose of digoxin.
- C. Continue the current dose of digoxin.
- D. Administer potassium supplements.
Correct answer: A
Rationale: The correct answer is to hold the digoxin and notify the healthcare provider. A potassium level of 2.8 mEq/L indicates hypokalemia, which can increase the risk of digoxin toxicity. Holding the medication and informing the healthcare provider is crucial to prevent adverse effects. Choice B is incorrect because increasing the dose of digoxin would further raise the risk of toxicity. Choice C is incorrect as continuing the current dose could exacerbate the toxicity risk. Choice D is incorrect because administering potassium supplements alone is not sufficient to address the potential digoxin toxicity; the first step should be to hold the digoxin and seek further guidance.
Similar Questions
Access More Features
ATI RN Basic
$69.99/ 30 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access
ATI RN Premium
$149.99/ 90 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access